01:30 PM GMT, United States - Philadelphia Fed Manufacturing Index for November:
- Manufacturing Index: actual -1.7; forecast 1.0; previous -12.8;
- Business Conditions: actual 49.6; previous 36.2;
- Employment: actual 6.0; previous 4.6;
- New Orders: actual -8.6; previous 18.2;
- Prices Paid: actual 56.10; previous 49.20;
- CAPEX Index: actual 26.70; previous 25.20;
Regional manufacturing softened in November as new orders and shipments turned negative and overall activity remained below zero, despite a small uptick in the headline index. Firms continued to add jobs, and price pressures persisted, with input costs rising sharply. Companies expect both their own prices and U.S. consumer inflation to grow more slowly than previously forecast, while customer price sensitivity has increased. Despite weaker current conditions, expectations for the next six months strengthened notably, with future activity, new orders, and capital spending all pointing to a more optimistic outlook.
We are seeing an increase in EURUSD and a sharp decline in the USD, but the reaction is mostly driven by the release of overdue labor-market data.
Palo Alto - after Earnings
BREAKING: US100 ticks higher after NFP upbeat data release 💡
Chart of the day: US100 (20.11.2025)
BREAKING: German PPI slightly above expectations!
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.